Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency

NCT05796440 is registered in ClinicalTrials.gov with Lumos Pharma as lead sponsor.

NCT NCT05796440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children With Idiopathic Growth Hormone Deficiency
Lead sponsor
Lumos Pharma
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
August 1, 2023
Completion date
April 30, 2028
Enrollment
60 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency